RENVELA 800 mg, film-coated tablet 180 tablets
Active ingredients: Sevelamer carbonate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet180 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RENVELA 800 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 180 comprimé(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Excès de phosphore dans le sang chez les personnes adultes sous dialyse (reins artificiels) ou en dont les reins ne fonctionnent pas correctement. ; JOURNAL OFFICIEL ; 28/09/10
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Oct 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61136926CIP73967027CIP133400939670270Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBONATE DE SÉVÉLAMERcomprimé | 800 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.